Brief: FMC AG - Refines China Commercial Strategy, Expects One-Time Costs Of €110 Million in Q3
BRIEF-FMC AG - Refines China Commercial Strategy, Expects One-Time Costs Of €110 Million in Q3 Sept 25 (Reuters) - FRESENIUS MEDICAL CARE AG FMEG.DE:
FMC AG - FRESENIUS MEDICAL CARE REFINES CHINA COMMERCIAL STRATEGY WITH A FOCUS ON LONG-TERM GROWTH AND MARKET LEADERSHIP
FMC AG - PORTFOLIO DECISIONS EXPECTED TO RESULT IN RELATED ONE-TIME COSTS IN Q3 2026 TREATED AS A SPECIAL ITEM
FMC AG - PORTFOLIO OPTIMIZATION ACTIONS ARE EXPECTED TO RESULT IN ONE-TIME COSTS OF €110 MILLION
Further company coverage: FMEG.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Fresenius Medical Care AG
See all newsFMC seen down as Fresenius cuts stake to 20%
Germany's Fresenius cuts FMC stake to 20%
Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital
Brief: Fresenius Medical Care AG ABB Orders Below Eur 39.00 Per Share, Says Book Runner
Brief: Bookrunner Says Fresenius Medical ABB C. 13.4 Mln Shares, Books Are Closed